INTELLIA THERAPEUTICS INC shareholders Q3 2023

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 203,684$6,440,4880.43%
Contrarius Investment Management Ltd 231,862$7,3310.41%
McGuire Investment Group, LLC 65,984$2,086,4140.40%
Menard Financial Group LLC 8,392$265,3550.38%
Artal Group S.A. 276,077$8,7300.37%
Green Alpha Advisors, LLC 14,777$467,2490.36%
Rokos Capital Management LLP 1,389,296$44,311,5960.32%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$757,9200.26%
Interchange Capital Partners, LLC 9,634$304,6300.24%
Granahan Investment Management 205,191$6,488,1390.23%
Value Star Asset Management (Hong Kong) Ltd 20,700$654,5340.23%
Corton Capital Inc. 14,088$445,4630.22%
Eventide Asset Management 372,665$11,783,6670.21%
CAPITAL ADVISORS INC/OK 211,359$6,683,1720.18%
Rhenman & Partners Asset Management AB 50,000$1,581,0000.17%
FEDERATED HERMES, INC. 1,771,578$56,017,2960.15%
PDT Partners, LLC 37,077$1,172,3750.15%
Chevy Chase Trust Holdings, LLC 1,002,955$31,713,4370.12%
HARBOR CAPITAL ADVISORS, INC. 16,604$525,0180.11%
AIGEN INVESTMENT MANAGEMENT, LP 17,569$555,5320.10%
External links

This page lists INTELLIA THERAPEUTICS INC's shareholders in Q3 2023. To view INTELLIA THERAPEUTICS INC's shareholder history, click here.